A real-world characterization of a population with eosinophilic esophagitis: looking for severity biomarkers

被引:0
|
作者
Caldeira, Leonor esteves [1 ]
Limao, Rita [1 ]
Bras, Rita [1 ]
Pedro, Elisa [1 ]
Costa, Celia [1 ,2 ]
机构
[1] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Dept Immunoallergol, Lisbon, Portugal
[2] Univ Clin Immunoallergol, Med Fac Lisbon, Lisbon, Portugal
关键词
Atopy; eosinophilic esophagitis; food allergy; sensitization; severity biomarkers; HISTOLOGIC REMISSION; GUIDELINES; MANAGEMENT; DIAGNOSIS; EFFICACY; CHILDREN;
D O I
10.23822/EurAnnACI.1764-1489.292
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background. Eosinophilic esophagitis (EoE) is an immune-mediated chronic esophageal disease, with frequent association with atopy. A vali- dated non/minimally invasive biomarker of disease severity has not been identified. We aimed to determine if sensitization to airborne , food allergens correlates with disease severity , to evaluate the association between clinical and laboratory characteristics with the severity of EoE. Methods. Retrospective study of EoE patients observed in a differentiated center, 2009-2021. The association between patients' diagnosis age, disease duration before diagnosis, sensitization to airborne/food allergens, serum total IgE and peripheral blood eosinophil values and severe clinical disease (presence of symptoms with a significant impact on quality of life and/or >= 1 hospital admission due to EoE complications, namely severe dysphagia, food impaction or esophageal perforation) and histological severe disease (>= 55 eos/hpf and/or microabscesses in esophageal biopsies) was evaluated. Results. 92 patients were observed, 83% male, 87% atopic. There was a mean delay in diagnosis of 4 years (range 0-31). 84% had aeroallergen sensitization and 71% food sensitization. Food impaction and dysphagia were the most frequent symptoms, and severe clinical disease was observed in 55%. Histologically, 37% had severity criteria. Patients with severe clinical disease had a significantly longer mean disease duration before diagnosis than patients without severe clinical disease (79 vs 15 months; p = 0.021). Patients who described food impaction were significantly older at time of diagnosis than those who have never had impaction (18 vs 9 years; p < 0.001). There was no significant association (p < 0.05) between sensitization, serum total IgE and peripheral blood eosinophil values and clinical or histological severity. Conclusions. An older age at diagnosis and a longer disease duration before diagnosis appear to be useful for pre- dicting EoE clinical severity. Despite having been demonstrated a high prevalence of allergic disease, the presence of sensitization to airborne and/ or food allergens do not seem to be useful for predicting clinical or histo- logical severity.
引用
收藏
页码:252 / 262
页数:11
相关论文
共 50 条
  • [21] A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis
    Philobos, Mariana
    Perkins, Amy
    Karabayas, Maira
    Dospinescu, Paula
    Fluck, Nick
    Kidder, Dana
    Chapman, Fiona A.
    Dhaun, Neeraj
    Basu, Neil
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (10) : 1811 - 1814
  • [22] Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States
    Huang, Amy H.
    Roh, Youkyung Sophie
    Sutaria, Nishadh
    Choi, Justin
    Williams, Kyle A.
    Canner, Joseph K.
    Grossberg, Anna L.
    Kwatra, Shawn G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 893 - 900
  • [23] Population pharmacokinetics and dosing optimization of perampanel in children with epilepsy: A real-world study
    Li, Sichan
    Yi, Jiaqin
    Tuo, Yali
    Nie, Gang
    Wang, Jun
    Wang, Yang
    Sun, Dan
    Liu, Zhisheng
    EPILEPSIA, 2024, 65 (06) : 1687 - 1697
  • [24] Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study
    Rezende Macedo do Nascimento, Renata Cristina
    Mueller, Tanja
    Godman, Brian
    MacBride Stewart, Sean
    Hurding, Simon
    Assis Acurcio, Francisco
    Guerra Junior, Augusto Afonso
    Alvares Teodoro, Juliana
    Morton, Alec
    Bennie, Marion
    Kurdi, Amanj
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (12) : 2349 - 2361
  • [25] Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
    Campisi, Raffaele
    Nolasco, Santi
    Pelaia, Corrado
    Impellizzeri, Pietro
    D'Amato, Maria
    Portacci, Andrea
    Ricciardi, Luisa
    Scioscia, Giulia
    Crimi, Nunzio
    Scichilone, Nicola
    Barbaro, Maria Pia Foschino
    Pelaia, Girolamo
    Carpagnano, Giovanna Elisiana
    Vatrella, Alessandro
    Crimi, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [26] A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
    Vano Galvan, Sergio
    Maria Piraccini, Bianca
    Reygagne, Pascal
    Farrant, Paul
    Reed, Catherine
    Johansson, Erin
    Marwaha, Simran
    Durand, Frederick
    Blume-Peytavi, Ulrike
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 648 - 656
  • [27] Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response
    Caminati, Marco
    Cegolon, Luca
    Vianello, Andrea
    Bianchi, Fulvia Chieco
    Festi, Giuliana
    Marchi, Maria R.
    Micheletto, Claudio
    Mazza, Francesco
    Tognella, Silvia
    Sennaon, Gianenrico
    Artioli, Denise
    Bertocco, Elisabetta
    Bonazza, Lucio
    Crivellaro, Mariangiola
    De Conti, Fabio
    Dama, Annarita
    Donazzan, Giulio
    Guarnieri, Gabriella
    Idotta, Giuseppe
    Lombardi, Carlo
    Marino, Luigi
    Nardini, Stefano
    Olivieri, Mario
    Reccardini, Federico
    Schiappoli, Michele
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) : 1205 - 1212
  • [28] Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma
    Kavanagh, Joanne E.
    d'Ancona, Grainne
    Elstad, Maria
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Roxas, Cris
    Dhariwal, Jaideep
    Nanzer, Alexandra M.
    Kent, Brian D.
    Jackson, David J.
    CHEST, 2020, 158 (02) : 491 - 500
  • [29] Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma - "first initiators" and "switchers"
    Hashimoto, S.
    Kroes, J. A.
    Eger, K.
    Mau-Asam, P.
    Hofstee, H. B.
    Bendien, S. A.
    Braunstahl, G.
    Broeders, M. E.
    Imming, L. M.
    Langeveld, B.
    Maitland-Van der Zee, A. H.
    Oud, K. T.
    Patberg, K. W.
    Smeenk, F. W.
    Romme, E. A.
    Van Bezouw, M. J.
    Van de Ven, M. J.
    Van Veen, A.
    Van Velzen, E.
    Van Veen, I. H.
    Weersink, E. J.
    Ten Brinke, A.
    Sont, J. K.
    Bel, E. H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] Effectiveness and Tolerability of Aripiprazole in a Real-World Outpatient Population of Youth
    Bildik, Tezan
    Ozbaran, Nazli Burcu
    Kose, Sezen
    Cetin, Saniye Korkmaz
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 22 (03): : 225 - 234